BusinessAbeona Therapeutics Announces Presentations and Posters at the 13th Annual WORLDSymposium™ 2017By Nasdaq OMXFeb 7, 2017, 12:45 PM UTC
BusinessAbeona Therapeutics Enrolls First High Dose Subject in Ongoing Phase 1/2 Gene Therapy Clinical Trial in Sanfilippo Syndrome Type ABy Nasdaq OMXFeb 1, 2017, 12:43 PM UTC
